Standardization and quality control in PET imaging: Advances, challenges, and clinical implications.
Positron emission tomography (PET) has transformed diagnostic imaging and therapeutic monitoring by enabling quantitative assessment of molecular processes in vivo. However, reliable use of standardized uptake values (SUVs) and other PET-derived biomarkers requires strict quality assurance (QA), harmonization, and continuous performance monitoring.
Positron emission tomography (PET) has transformed diagnostic imaging and therapeutic monitoring by enabling quantitative assessment of molecular processes in vivo. However, reliable use of standardized uptake values (SUVs) and other PET-derived biomarkers requires strict quality assurance (QA), harmonization, and continuous performance monitoring.
What the study was
- Study design
- Review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Radiography (Lond)
Why it surfaced
Matched watchlist topic 'Precision oncology and genomic medicine'. Study design: Review. Score: 8/10 (N:2, R:3, D:1, P:2).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.